Aode Aode-312 Pharmacopoeial Angle of Repose Tester

Overview

The Aode Aode-312 Pharmacopoeial Angle of Repose Tester is a precision-engineered instrument designed for standardized static angle of repose measurement in accordance with the Chinese Pharmacopoeia 2025 Edition, Volume IV, General Chapter 9604. It implements the fixed-cone (residual cone) method — a gravimetric, geometry-based technique wherein powder is centrally deposited onto a circular base plate until overflow occurs at the periphery; after 2 minutes of stabilization, the height and radius of the resulting conical pile are measured to compute tanθ = h/r, yielding the angle of repose (θ) in degrees. This parameter serves as a primary empirical indicator of bulk powder flow behavior under gravity-driven conditions, widely adopted in pharmaceutical formulation development, quality control of active pharmaceutical ingredients (APIs), excipients, and granules, as well as in chemical, detergent, and materials science laboratories. The instrument operates independently or via USB interface with dedicated PC software, enabling automated calculation, traceable data logging, and pharmacopoeia-aligned reporting.

Key Features

• Pharmacopoeia-compliant design aligned with CP 2025 Vol. IV 9604 methodology, supporting regulatory submissions and internal QC workflows.
• Dual-base plate configuration (100 mm and 80 mm diameters) with raised central platform ensures consistent sample confinement and reproducible cone formation.
• Interchangeable stainless steel funnels with six calibrated outlet diameters (5–10 mm, 1 mm increments) allow systematic evaluation of particle–orifice interaction effects on flow dynamics.
• AISI 304 stainless steel construction throughout — including funnel, base plate, and housing — guarantees corrosion resistance, cleanability, and long-term dimensional stability required for GMP environments.
• Included 30° reference calibration cone enables periodic verification of geometric accuracy and system linearity per ISO/IEC 17025 metrological traceability principles.
• Integrated measurement capability extends beyond angle of repose to include flow time, discharge mass, and bulk density — facilitating multi-parameter flow profiling per USP <1174> and ASTM D6393.

Sample Compatibility & Compliance

The Aode-312 accommodates powders and granules within a particle size range of 1–5000 µm, covering fine APIs, milled excipients, spray-dried particles, and coarser agglomerates. Its minimum sample requirement of 10 mL and maximum capacity of 520 mL support both high-throughput screening and low-volume R&D testing. The 1 mm aperture sieve ensures de-agglomeration prior to deposition, minimizing bridging artifacts. All operational procedures conform to CP 2025 9604, and the instrument’s mechanical repeatability supports GLP/GMP documentation requirements. While not FDA 21 CFR Part 11–certified out-of-the-box, its audit-trail-capable software (when configured with timestamped user login and electronic signature modules) meets foundational data integrity expectations for regulated labs.

Software & Data Management

The optional Windows-based analysis software provides real-time acquisition, automatic θ calculation, and generation of compliant test reports including raw height/radius values, derived angle, flow classification index (e.g., “excellent”, “good”, “fair”, “poor”), and pass/fail flags against user-defined specification limits. Data files are saved in CSV and PDF formats, supporting LIMS integration and long-term archival. Each report includes instrument ID, operator name, date/time stamp, environmental notes (optional), and calibration status. Software architecture permits configurable test templates, batch processing, and export to Excel-compatible spreadsheets for statistical process control (SPC) analysis.

Applications

• Pharmaceutical solid dosage form development: excipient selection, blend uniformity assessment, tablet compression feasibility studies.
• QC release testing of raw materials and intermediates per pharmacopoeial monographs.
• Stability-indicating flow monitoring during accelerated storage trials.
• Research into humidity-, temperature-, or shear-induced flow degradation mechanisms.
• Validation of milling, granulation, or drying process endpoints via flow parameter trending.
• Comparative benchmarking across powder suppliers or manufacturing sites.

FAQ

What pharmacopoeial standards does the Aode-312 comply with?
It conforms to the Chinese Pharmacopoeia 2025 Edition, Volume IV, General Chapter 9604 — the official guidance for powder flowability assessment in China.
Can the instrument measure parameters other than angle of repose?
Yes: flow time, discharged mass, and bulk density are concurrently recorded during each test cycle.
Is calibration traceable to national standards?
The included 30° stainless steel calibration cone allows functional verification; users may establish traceability through accredited metrology labs using angular gage blocks or optical autocollimators.
What sample volume is required for reliable results?
Minimum recommended volume is 10 mL; optimal consistency is achieved between 50–300 mL depending on powder density and compressibility.
Does the system support 21 CFR Part 11 compliance?
The base software does not include electronic signatures or audit trail features by default, but can be extended via validated third-party add-ons meeting Part 11 requirements.